Elgendy, Abdalhakim Shubietah Endocrinology, Diabetes & Metabolism.2026;[Epub] CrossRef Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown Edoardo Mannucci, Ilaria Dicembrini Nature Reviews Clinical Oncology.2026
Potential anticarcinogenic peptides from bovine milk
The data show that the drugs have a wide array of beneficial effects but not without risks, Ziyad Al-Aly , MD, FASN , an assistant professor of medicine at the Washington University School of Medicine in St
That means it is designed to act on three metabolic hormone pathways: Most people are already familiar with GLP-1 medications because of drugs like Ozempic, Wegovy, Mounjaro, and Zepbound
Helps our bodies fight infection, disease, inflammation, and autoimmunity.